Abstract
The potent and wide-ranging biologic activities of PAF are well documented (see Chapters 11–20). Nevertheless, we still have not determined when and where, in endogenous physiologic and pathologic processes, PAF is actually playing a role. In this chapter, I discuss some of the issues relating to where PAF may act and the nature of its biologic properties. Of necessity, the consideration is somewhat speculative, since the appropriate studies to address these questions are really only in their infancy. Moreover, because of the extensive discussion of the properties of PAF in this book, the references should be considered as illustrative and not exhaustive. Hopefully, the ideas elaborated herein will provide at the minimum an inducement for further investigation. It is even possible that this chapter will provide the beginnings of a framework that can be used to place the ether phospholipids now known as PAF into their proper context in pathophysiologic processes. For this discussion, the term PAF is used generically for molecules with structures and biologic activity similar to, or identical with, hexadecyl acetyl glycerophospho-choline.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Accurso, F. J., Abman, S., Wilkening, R. B., Worthen, S., and Henson, P. M., 1986, Exogenous platelet activating factor produces pulmonary vasodilation in the ovine fetus, Am. Rev. Resp. Dis. 133(Suppl. 4):A11.
Albert, D. H., and Snyder, F., 1984, Release of arachidonic acid from l-alkyl-2-acykv«-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages, Biochem. Biophys. Acta 796:92–101.
Alonso, F., Garcia-Gil, M., Sanchez-Crespo, M., and Mato, J. M., 1982, Activation of l-alkyl-2-lyso-glycero-3-phosphocholine acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes, J. Biol. Chem. 257:3376–3378.
Arnold, B., and Weltzien, H. U., 1976, Effects of a synthetic lysolecithin analog on the phase transition of mixtures of phosphatidylethanolamine and phosphatidylcholine, FEBS Lett. 61(2): 199–202.
Benveniste, J., 1986, Comments in New Horizons in Platelet Activating Factor Research (C. M. Winslow and M. C. Lee, eds.), Wiley, New York.
Benveniste, J., Roubin, R., Chignard, M., Jouvin-Marche, E., and LeCouedic, P., 1982, Release of platelet-activating factor (PAF-acether) and 2-lysoPAF-acether from three cell types, Agents Actions 12:711–713.
Billah, M. M., and Johnston, J. M., 1983, Identification of phospholipid platelet-activating factor (1–0alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine, Biochem. Biophys. Res. Commun. 113:51–58.
Blank, M. L., Snyder, F., Byers, L. W., Brooks, B., and Muirhead, E. E., 1979, Antihypertensive activity of an alkyl ether analog of phosphatidylcholine, Biochem. Biophys. Res. Commun. 90:1194–2000.
Blank, M. L., Cress, E. A., Lee, T.-C., Malone, B., Surles, J. R., Piantadosi, C., Hajdu, J., and Snyder, F., 1982, Structural features of platelet activating factor (l-alkyl-2-acetyl-sn-glycero-3phosphocholine) required for hypotensive and platelet serotonin responses, Res. Commun. Chem. Pathol. Pharmacol. 38:3–20.
Bussolino, F., Gremo, F., Tetta, C., Pescarmona, G. P., and Camussi, G., 1986, Production of platelet activating factor by chick retina, J. Biol. Chem. 261:16502–16508.
Chang, S., Fedderson, O., Worthen, G. S., Henson, P. M., and Voelkel, N., 1986, CV3988, a PAF antagonist and ethanol protect against endotoxin-induced hemodynamic alterations in rat, in: New Horizons in Platelet Activating Factor Research (C. M. Winslow and M. L. Lee, eds.), Wiley, New York, pp. 293–301.
Chenoweth, D. E., and Hugh, T. E., 1978, Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA 75:3943–3947.
Chesney, C. M., Pifer, D. O., and Hugh, K. M., 1985, Desensitization of human platelets by platelet activating factor, Biochem. Biophys. Res. Commun. 127:24–30.
Chilton, F. H., and Murphy, R. C, 1986, Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil, J. Biol. Chem. 261:7771–7777.
Clay, K. F., and Baker, R. C, 1985, Determination of platelet activating factor in mouse brain tissue. Proceedings of the 33rd Annual Conference on Mass Spectrometry and Allied Topics, pp. 700– 701, A.
Cox, C. P., Wardlow, M. C., Jorgensen, R., and Farr, R. S., 1981, The presence of platelet activating factor (PAF) in normal human mixed saliva, J. Immunol. 127:46–50.
Goetzl, E. J., Derian, C. K., Tauber, A. I., and Valone, F. H., 1980, Novel effects of l-O-hexadecyl-2acyl-srt-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituents, Biochem. Biophys. Res. Commun. 94:881–888.
Gomez-Cambronero, J., Dieto, M. L., Mato, J. M., and Sanchez-Crespo, M., 1985a, Modulation of lyso-platelet-activating factor : acetyl-CoA acetyl transferase from rat splenic microsomes. The role of calcium ions, Biochem. Biophys. Acta 845:511–515.
Gomez-Cambronero, J., Velasco, S., Mato, J. M., Sanchez-Crespo, M., 1985b, Modulation of lysoplatelet activating factor : acetyl-CoA acetyl transferase from rat splenic microsomes. The role of cyclicAMP-dependent protein kinase, Biochem. Biophys. Acta 845:516–519.
Grandel, K. E., Farr, R. S., Wanderer, A. A., Sisenstadt, T. C., and Wasserman, S. I., 1985, Association of platelet-activating factor with primary acquired cold urticaria, N. Engl. J. Med. 313:405–409.
Hadvary, P., and Baumgartner, H. R., 1983, Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor, Thrombosis Res. 30:143–156.
Harris, R. A., Clay, K., Murphy, R., and Henson, P., 1985, Effects of PAF and related lipids on membrane physical properties, Fed. Proc. 44:858.
Henson, P. M., 1971, The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagcytosable surfaces, J. Immunol. 107:1547–1557.
Henson, P. M., 1976, Activation and desensitization of platelets by platelet activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response, J. Exp. Med. 143:937–952.
Henson, P. M., and Pinckard, R. N., 1977, Basophil derived platelet activating factor (PAF) as an in vivo mediator of acute allergic reactions. Demonstration of specific desensitization of platelets to PAF during IgE-induced anaphylaxis in the rabbit, J. Immunol. 119:2179–2184.
Hwang, S., Lam, M., and Pong, S., 1986, Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes, J. Biol. Chem. 261(2):532–537.
Hwang, S.-B., Lee, C.-S., C., Cheah. M. J., and Shen, T. Y., 1983. Specific receptor sites for 1–0alkyl-2–0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes, Biochemistry 22:4756–4763.
Jain, M. K., and DeHaas. G. H., 1985, Activation of phospholipase A2 by freshly added lysophospholipids, Biochem. Biophys. Acta 736:157–162.
Keraly, C. L., and Benveniste. J., 1982, Specific desensitization of rabbit platelets by platelet activating factor (Paf-acether) and derivatives, Br. J. Haematol. 51:313–322.
Klopfenstein, W. E., deKruyff, B., Verkleij, A. J., andDemel, R. A., and vanDeenen, L. L. M., 1974, Differential scanning calorimetry on mixtures of lecithin, lysolecithin and cholesterol. Chem. Phys. Lipids 13:215–222.
Krilis, S., Lewis, R. A., Corey, E. J., and Austen, K. F., 1983, Specific receptors for leukotriene C4 on a smooth muscle cell line, J. Clin. Invest. 72:1516–1519.
Krilis, S., Lewis, R. A., Corey, E. J., and Austen. K. F., 1984, Specific binding of leukotriene C4 to ileal segments and subcellular fractions of ileal smooth muscle cells, Proc. Natl. Acad. Sci. USA 81:4529–4533.
Kumar, R., King, R. J., and Hanahan, D. J., 1986, Processing of platelet activating factor (PAF) by interstitial and epithelial cells from rat lungs, in: New Horizons in Platelet Activating Factor Research (C. M. Winslow and M. L. Lee, eds.), Wiley, Chichester, pp. 97–102.
Lambrecht, G., and Parnham, M. J., 1986, Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes, Br. J. Pharmacol. 87:287–289.
Lee, T.-C., 1985, Biosynthesis of platelet activating factor. Substrate specificity of l-alkyl-2-lyso-snglycero-3-phosphocholine : acetyl-CoA acetyltransferase in rat spleen microsomes, J. Biol. Chem. 260:10952–10955.
Leslie, C. C., and Detty, D. M., 1986, Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages, Biochem. J. 236:251–259.
Ludwig, J. C., Hoppens, C. L., McManus, L. M., Mott, G. E., and Pinckard, R. N., 1985, Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular albumin, Arch. Biochem. Biophys. 241:337–347.
Ludwig, J. C., McManus, L. M., Clark, P. D., Hanahan, D. J., and Pinckard, R. N., 1984, Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): Role of extracellular calcium, Arch. Biochem. Biophys. 232:102–110.
Lumb, R. H., Pool, G. L., Bubacz, D. G., Blank, M. L., and Snyder, F., 1983, Spontaneous and protein-catalyzed transfer of l-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) between phospholipid bilayers, Biochem. Biophys. Acta 750:217–222.
Lynch, J. M., and Henson, P. M., 1986, The intracellular retention of newly synthesised platelet activating factor, J. Immunol. 137:2653–2661.
Lynch, J. M., Spears, P., and Henson, P. M., 1982, The specific inhibition of platelet activating factor (PAF) stimulation of rabbi rabbit platelets by a monoclonal antiplatelet antibody, Fed. Proc. 41:528.
Mallet, A. I., and Cunningham, F. M., 1985, Structural identification of platelet activating factor in psoriatic scale, Biochem. Biophys. Res. Commun. 126:192–198.
Mangold, H. K., and Paltauf, F. (eds.), 1983, Ether Lipids. Biochemical and Biomedical Aspects, Academic Press, New York.
McMurtry, I. F., Morris, K. G., 1986, Platelet activating factor causes pulmonary vasodilation in the rat, Am. Rev. Respir. Dis. 134:757–762.
Murphy, R. C., and Henson, P. M., 1985, Mediator network, Ann. Inst. Pasteur/Immunol. 136D:175– 228.
Neufeld, E. J., Majerus, P. W., Krueger, C. M., and Saffitz, J. E., 1985, Uptake and subcellular distribution of (3H) arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography, J. Cell Biol. 101:573.
Ninio, E., 1986, Regulation of PAF-acether biosynthesis in different cell types, in: New Horizons in Platelet Activating Factor Research (C. M. Winslow and M. L. Lee, eds.), Wiley, New York.
O’Flaherty, J. T., Lees, C. J., Miller, C. H., McCall, C. E., Lewis, J. C., Love, S. H., and Wykle, R. L., 1981, Selective desensitization of neutrophils: Further studies with l-O-alkyl-srt-glycero-3phosphocholine analogues, J. Immunol. 127:731–737.
O’Flaherty, J. T., Surles, J. R., Redman, J., Jacobson, D., Piantadosi, C., Wykle, R. L., 1986, Binding and metabolism of platelet activating factor by human neutrophils, J. Clin. Invest. 78:381–388.
Pinckard, R. N., Farr, R. S., and Hanahan, D. J., 1979, Physiochemical and functional identification of rabbit platelet activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitive basophils, J. Immunol. 123:1847–1857.
Riches, D. W. H., Young, S. K., Seccombe, J. F., Lynch, J. M., and Henson, P. M., 1985, The subcellular distribution of platelet-activating factor (PAF) in phagocytosing human neutrophils, Fed. Proc. 44:137.
Roubin, R., Mencia-Huerta, J.-M., and Benveniste, J., 1982, Release of platelet-activating factor (Pafacether) and leukotrienes C and D from inflammatory macrophages, Eur. J. Immunol. 12:141–146.
Sanchez-Crespo, M., Inarrea, P., Alvarez, V., Alonso, F., Egido, J., and Hernando, L., 1983, Presence in normal human urine of a hypotensive and platelet-activating phospholipid, Am. J. Physiol. 244:F706–F711.
Satouchi, K., Pinckard, R. N., McManus, L. M., and Hanahan, D. J., 1981, Modification of the polar head group of acetyl glyceryl ether phosphoryl choline and subsequent effects upon platelet activation, J. Biol. Chem. 256:4425–4432.
Shaw, J. O., and Henson, P. M., 1980, The binding of rabbit basophil-derived platelet activating factor to rabbit platelets, Am. J. Pathol. 98:791–810.
Shen, T. Y., Hwang, S. B., Cheah, M. J., and Lee, C.-S. C., 1983, Effects of nonsteroidal antiinflam matory drugs on the specific binding of platelet-activating factor to membrane preparations of rabbit platelets, in: Platelet-Activating Factor and Structurally Related Ether Lipids (J. Benveniste and B. Arnoux, eds.), Elsevier Science Publishers, Amsterdam, pp. 167–176.
Snyder, F., 1986, The significance of dual pathwavs for the biosynthesis of platelet activating factor: Alkyl acetyl glycerols and lyso-PAF as immediate precursors, in: New Horizons in Platelet Activating Factor Research (C. M. Winslow and M. L. Lee, eds.), Wiley, New York, pp. 13–25.
Snyderman, R., Pike, M. C., Edge, S., and Lane, B., 1984, A chemoattractant receptor on macrophages exists in two affinity states regulated by guanine nucleotides, J. Cell Biol. 98:444–448.
Stenmark, K., Eyzaguirre, R., Remigio, L., Seccombe, J., and Henson, P. M., 1985, Recovery of platelet activating factor and leukotrienes from infants with severe bronchopulmonary dysplasia: Clinical improvement with cromolyn treatment, Am. Rev. Resp. 131:A236.
Stimler, N., Parasympathetic stimulation as a mechanism for PAF-induced contractile responses in lung, in: New Horizons in Platelet Activating Factor Research (C.M. Winslow and M. L. Lee, eds.), Wiley, Chichester, pp. 269–275.
Valone, F. H., 1984, Isolation of a platelet membrane protein which binds the platelet-activating factor l-0-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine, Immunology 52:169–174.
Valone, F. H., Coles, E., Reinhold, V. R., and Goetzl, E. J., 1982, Specific binding of phospholipid platelet-activating factor by human platelets, J. Immunol. 129:1637–1641.
VanEchteld, C. J. A., DeKruiff, B., and DeGier, J., 1980, Differential miscibility properties of various phosphatidylcholine/lysophosphatidylcholine mixtures, Biochem. Biophys. Acta 595:71–81.
Voelkel, N. F., Chang, S., Worthen, G. S., McMurtry, I., and Henson, P. M., 1986, PAF antagonists:Different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung, Prostaglandins 32(3):359–372.
Weltzien, H. U., 1979, Cytolytic and membrane-perturbing properties of lysophosphatidylcholine, Biochem. Biophys. Acta 559:259–287.
Wykle, R. L., Miller, C. H., Lewis, J. C., Schmitt, J. D., Smith, J. A., Surles, J. R., Piantadosi, C.,and O’Flaherty, J. T., 1981, Stereospecific activity of l-0-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils, Biochem. Biophys. Res. Commim. 100:1651–1658.
Zilversmit, D. B., 1984, Lipid transfer proteins, J. Lipid Res. 25:1563–1569.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Henson, P.M. (1987). Extracellular and Intracellular Activities of PAF. In: Snyder, F. (eds) Platelet-Activating Factor and Related Lipid Mediators. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5284-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5284-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5286-0
Online ISBN: 978-1-4684-5284-6
eBook Packages: Springer Book Archive